A pilot study of cystic fibrosis exacerbation response phenotypes reveals contrasting serum and sputum iron trends

The cystic fibrosis (CF) community seeks to explain heterogeneous outcomes of pulmonary exacerbation (PEX) treatment. Serum and sputum inflammatory mediators may identify people with CF (PwCF) at risk for suboptimal responses. However, lack of an established association between response phenotypes a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gifford, Alex H., Polineni, Deepika, He, Jianghua, D’Amico, Jessica L., Dorman, Dana B., Williams, Molly A., Nymon, Amanda B., Balwan, Akshu, Budden, Theodore, Zuckerman, Jonathan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921142/
https://www.ncbi.nlm.nih.gov/pubmed/33649353
http://dx.doi.org/10.1038/s41598-021-84041-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7921142/
https://www.ncbi.nlm.nih.gov/pubmed/33649353
http://dx.doi.org/10.1038/s41598-021-84041-y

Ejemplares similares